Detalhe da pesquisa
1.
Humoral immune depression following autologous stem cell transplantation is a marker of prolonged response duration in patients with mantle cell lymphoma.
Haematologica
; 107(9): 2163-2172, 2022 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35172560
2.
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.
N Engl J Med
; 379(10): 934-947, 2018 09 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30184451
3.
Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T3 phase IB trial of the LYSA.
Ann Hematol
; 99(8): 1771-1778, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-32601796
4.
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.
Lancet
; 388(10044): 565-75, 2016 Aug 06.
Artigo
Inglês
| MEDLINE | ID: mdl-27313086
5.
Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial.
Lancet Oncol
; 17(8): 1081-1093, 2016 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-27345636
6.
Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma - a phase II study.
Haematologica
; 106(3): 859-862, 2021 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32381571
7.
Efficacy of anti-PD1 re-treatment in patients with Hodgkin lymphoma who relapsed after anti-PD1 discontinuation.
Haematologica
; 105(11): 2664-2666, 2020 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33131257
8.
Transfusion needs after CAR T-cell therapy for large B-cell lymphoma: predictive factors and outcome (a DESCAR-T study).
Blood Adv
; 8(6): 1573-1585, 2024 Mar 26.
Artigo
Inglês
| MEDLINE | ID: mdl-38181767
9.
High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network.
J Clin Oncol
; 41(3): 479-484, 2023 01 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36469833
10.
Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R2) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma.
J Clin Oncol
; 40(28): 3239-3245, 2022 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35947804
11.
The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA.
Blood Adv
; 5(7): 1991-2002, 2021 04 13.
Artigo
Inglês
| MEDLINE | ID: mdl-33843986
12.
Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years.
Cancers (Basel)
; 13(18)2021 Sep 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34572728
13.
Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trial.
Lancet Haematol
; 8(9): e648-e657, 2021 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-34450102
14.
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma.
Leukemia
; 35(9): 2672-2683, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-33658659
15.
Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma.
J Clin Oncol
; 37(34): 3291-3299, 2019 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31609651
16.
Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study.
J Clin Oncol
; 36(22): 2259-2266, 2018 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29584548